A selfie and a smartphone app could catch pancreatic cancer early

BilliScreen uses machine learning algorithms to measure the amount of bilirubin in a person's eyes from a photo. (University of Washington)

While pancreatic cancer is relatively rare in the U.S., it is a leading cause of cancer death because it’s difficult to diagnose early. A smartphone app and a 3D-printed box, developed by researchers from the University of Washington, could change that.

The app, dubbed BilliScreen, uses computer vision algorithms and machine learning algorithms to detect jaundice in a photo of a person’s eyes.  Specifically, it measures elevated levels of bilirubin in the sclera, the white part of the eye.  Jaundice, an early symptom of pancreatic cancer and a number of other diseases, is caused by a buildup of bilirubin.

Bilirubin levels can be measured by a blood test, but this requires a healthcare professional and is inconvenient for frequent testing. The noninvasive BilliScreen could facilitate the screening of individuals at risk of pancreatic cancer.

FREE DAILY NEWSLETTER

Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

A user takes a photo of his or her face using a smartphone camera, a pair of special glasses and a 3D-printed box that controls the eye’s exposure to light. In a 70-patient study, BilliScreen “correctly identified cases of concern 89.7% of the time,” compared to the blood test that detects bilirubin. The findings are published in Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies.

“The problem with pancreatic cancer is that by the time you’re symptomatic, it’s frequently too late,” said lead author Alex Mariakakis, a doctoral student at the Paul G. Allen School of Computer Science & Engineering. “The hope is that if people can do this simple test once a month—in the privacy of their own homes—some might catch the disease early enough to undergo treatment that could save their lives.”

RELATED: MIT researchers create implant to deliver drugs to pancreatic tumors

BilliScreen is based on research from the University of Washington’s Ubiquitous Computing Lab, which previously created a smartphone app that detects jaundice in newborns from a photo of their skin.

The team plans to improve the device design, aiming to eliminate the need of aids such as the light-controlling box and glasses. They will also test the app on a broader range of people at risk for jaundice and underlying conditions other than pancreatic cancer.

Suggested Articles

Janssen is planning its first completely virtual clinical trial, using personal smartphones and wearable devices with no in-person site visits.

Sensyne Health aims to bring its AI tools to America, and it’s enlisting IT giant Cognizant and data infrastructure specialist Agorai to help.

Californian RNA biotech Arrowhead will lose its COO and R&D head from next year but is hiring a new CMO and CSO to help steady its research exec team.